Just Happened! NEURALINK Second Human Trials! Elon Musk Reveals NEW Updates

Updated on: August 26,2024 0

Just Happened! NEURALINK Second Human Trials! Elon Musk Reveals NEW Updates

Updated on:August 26,2024 0

Why clinical trials stop: Researchers find a link between genetic evidence and trial outcome

by Helena Cornu,European Molecular Biology LaboratoryHierarchical clustering of stop reason similarity based on curation from Pak et al. and 447 additional stopped trials due to COVID-19. Credit

Updated on: August 26,2024 0

Why clinical trials stop: Researchers find a link between genetic evidence and trial outcome

by Helena Cornu,European Molecular Biology LaboratoryHierarchical clustering of stop reason similarity based on curation from Pak et al. and 447 additional stopped trials due to COVID-19. Credit

Updated on:August 26,2024 0

The Current State and Future Prospects of Synthetic Biology

Updated on: August 26,2024 0

The Current State and Future Prospects of Synthetic Biology

Updated on:August 26,2024 0

Using 3D-Printing to Stop Hair Loss

Updated on: August 23,2024 0

Using 3D-Printing to Stop Hair Loss

Updated on:August 23,2024 0

Advancements in Digital Pathology: The Role of AI and Large Language Models

While the advancements in AI and LLMs hold great promise for the field of digital pathology, it is essential to address the associated challenges and ethical considerations.

Updated on: August 19,2024 0

Advancements in Digital Pathology: The Role of AI and Large Language Models

While the advancements in AI and LLMs hold great promise for the field of digital pathology, it is essential to address the associated challenges and ethical considerations.

Updated on:August 19,2024 0

The phageome: A hidden kingdom within your gut

Updated on: August 15,2024 0

The phageome: A hidden kingdom within your gut

Updated on:August 15,2024 0

Lactate-driven regulatory pathway in dendritic cells serves as a novel therapeutic target for treating autoimmunity

Updated on: August 14,2024 0

Lactate-driven regulatory pathway in dendritic cells serves as a novel therapeutic target for treating autoimmunity

Updated on:August 14,2024 0

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Updated on: August 14,2024 0

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Updated on:August 14,2024 0

Study Warns: Common Antibiotics Can Trigger Severe Skin Reactions

Updated on: August 13,2024 0

Study Warns: Common Antibiotics Can Trigger Severe Skin Reactions

Updated on:August 13,2024 0

US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

In a significant leap forward for dental care, Boston-based company Perceptive has announced the completion of the world's first fully automated dental procedure on a human.

Updated on: August 13,2024 0

US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

In a significant leap forward for dental care, Boston-based company Perceptive has announced the completion of the world's first fully automated dental procedure on a human.

Updated on:August 13,2024 0

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.

Updated on: August 13,2024 0

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.

Updated on:August 13,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024 0